ACS Omega · 2022 · 23 citations · 34 references
MedicineNeurosciencePharmacologyMolecular PharmacologyPharmacodynamicsSystems PharmacologyCerebrovascular DiseaseHypoxic-ischemic Brain InjuryNetwork PharmacologyNeuroprotectionNeuroprotective PharmacologyStrokeCerebral Ischemia NeuroprotectionHypoxia-inducible Factor ActivationHypoxia-inducible Factor RegulationHypoxia-inducible Factor SignalingNeurological FunctionPharmacodynamic MechanismsStroke ModelsVascular Endothelial Growth Factor
. The molecular docking of core targets revealed that the docking between vascular endothelial growth factor A (VEGF-A) and emodin was the most efficient. Emodin pretreatment decreased the neurological score from 2.875 to 1.125. Moreover, emodin inhibited the degradation of occludin and claudin-5 caused by matrix metalloprotein kinase (MMP)-2/MMP-9, thereby protecting the BBB. Additionally, related proteins such as hypoxia-inducible factor-1α/VEGF-A and nuclear factor kappa B were down-regulated. Thus, emodin may play a protective role during cerebral ischemia reperfusion through mediation of the Hif-1α/VEGF-A signaling pathway to inhibit the expression of inflammatory factors.
34
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain
Zheng Gang Zhang, Li Zhang, Quan Jiang et al. · Journal of Clinical Investigation · 2000 · 1.3K citations · Full text
Medicine, Neurology, Neuroscience +16
STITCH: interaction networks of chemicals and proteins
Michael Kuhn, Christian von Mering, Mónica Campillos et al. · Nucleic Acids Research · 2007 · 1K citations · Full text
Pathophysiological consequences of VEGF-induced vascular permeability
Sara M. Weis, David A. Cheresh · Nature · 2005 · 897 citations